Search Results

Search Results

Research Study Search Results

Return to Search Form
  1. Neuroscience

      1. Brain Tumor

        1. Safety and Tolerability of TPI-287 in Adults with Recurrent Glioblastoma Who Have Progressed After Treatment with Avastin® Tara Benkers, MD
        2. Safety and Tolerability of TPI-287 in Adults with Recurrent Glioblastoma Who Have Not Been Previously Treated with Avastin® Tara Benkers, MD
        3. Open label trial of Nivolumab versus Avastin® in adults with recurrent GBM who have not been previously treated with Avastin®. Tara Benkers, MD
        4. An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The “ACT IV” Study) John Henson, MD
        5. A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors. Stephen Monteith, MD
        6. A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM John Henson, MD
        7. A Phase III Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme Charles Cobbs, MD
      2. Brain Tumor /Neurosurgery

        1. The Comprehensive Neuro-Oncology Data Repository (CONDR): Prospective Collection of Clinical Tissue and Imaging Data for the Study of Patients with Brain Tumors. Sarah C. Jost, MD
      3. Craniotomy /Interventional

        1. Intravenous acetaminophen for craniotomy patients Arthur M. Lam, M.D.
      4. Epilepsy

        1. Tissue Procurement and Repository for Future Neuroscience Studies Ryder Gwinn, MD
      5. Epilepsy /Genetic

        1. Protocol For Research of Genetic Epilepsy Marcio Sotero de Menezes, MD
      6. Growth Hormone Deficiency

        1. A phase 3, multicenter study designed to evaluate the efficacy and safety of a long-acting hGH product (MOD-4023) in adult subjects with growth hormone deficiency Kevin Yuen, MD
      7. Movement Disorders

        1. A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. Ryder Gwinn, MD
        2. Gamma Knife Thalamotomy for Treatment of Essential Tremor Christopher Loiselle, M.D.
      8. Multiple Sclerosis

        1. The Efficacy and Safety and Tolerability of Laquinimod in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) (CONCERTO) Peiqing Qian, MD
        2. Quantitative imaging of whole and gray matter demyelination in multiple sclerosis using macromolecular proton fraction mapping. James Bowen, MD
        3. JCV Antibody Program in patients with Relapsing MS and who are Receiving or Considering Treatment with Tysabri Lily Jung, MD
        4. Ibudilast versus placebo in subjects with progressive multiple sclerosis Pavle Repovic, MD
        5. Effectiveness of DMF and its impact on PROs in Suboptimal GA Responders with RMS (RESPOND) Pavle Repovic, MD
        6. A Phase 4 Multicenter, Open-Label, Single Arm study to evaluate switching from BRACET/Gilenya to Natalizumab in subjects with relapsing forms of Multiple Sclerosis(MS). Pavle Repovic, MD, PhD
        7. A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis James Bowen, MD
        8. A Multicenter Randomized Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects (REVEAL). Peiqing Qian, MD
        9. A 12-month, randomized, blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with multiple sclerosis. Lily Jung Henson, MD
        10. 101MS402 TYGRIS - Tysabri Global Observational Program in Safety Lily Jung, MD
      9. Neuromyelitis Optica (NMO)

        1. A randomized, double-blind, placebo-controlled, multi-center trial to evaluate the safety and efficacy of Eculizumab in patients with relapsing neuromyelitis optica (NMO) Pavle Repovic, MD
      10. Neuro-Ophthalmology

        1. Eli Lilly NAION Steven Hamilton, MD
      11. Parkinson's Disease

        1. A feasibility study to evaluate safety and initial effectiveness of Exablate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease. Ryder Gwinn, MD
      12. Pituitary Tumor /Acromegaly

        1. An acromegaly, open-label, multi-center, safety monitoring program for treating patients with SOM230 (pasireotide) LAR who have need to receive medical therapy (ACCESS) Kevin Yuen, MD
      13. Spine

        1. RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain Ryder Gwinn, MD
      14. Stroke

        1. Randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of dabigatran etexilate versus aspirin in patients with embolic stroke of undetermined source. Sheila Smith, MD
        2. MISTIE III - Treatment of intracerebral hemorrhage. David Newell, MD
        3. A phase IIIb double-blind multicenter study to evaluate the efficacy and safety of Alteplase in patients with mild stroke: rapidly improving symptoms and minor neurologic deficits (PRISMS) Aaron Stayman, MD